Clinical Trials Browser

cyclopia sequence, Emergence Delirium, Postoperative Cognitive Complications, Carcinoma, Renal Cell, Colonic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms

NCT01092481 2019-05-21

Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy

Phase 3 Unknown

1,580 enrolled

Gastrointestinal

Colonic Neoplasms

NCT03606863 2018-07-31

Peripheral Parenteral Nutrition vs Conventional Fluid in Colorectal Resection in ERAS

Phase 3 Unknown

200 enrolled

Gastrointestinal

Colonic Neoplasms, Hyperphagia

NCT02363049 2017-02-23

CLIMAT

Phase 3 Unknown

278 enrolled

Gastrointestinal

Colonic Neoplasms

NCT02912052 2016-09-23

PEPCORLI

Phase 3 Unknown

240 enrolled

Gastrointestinal

Colonic Neoplasms

NCT02852915 2016-08-04

Laparoscopic Surgery for T4 Tumor of the Colon Cancer

Phase 3 Unknown

1,960 enrolled

Gastrointestinal

Colonic Neoplasms

NCT02682589 2016-07-06

OLCMECC

Phase 3 Unknown

1,080 enrolled

Gastrointestinal

Colonic Neoplasms

NCT02280278 2014-11-05

Cytokine-induced Killer Cell Immunotherapy for Surgical Resected Stage III Colorectal Cancer Patients After Chemotherapy

Phase 3 Unknown

550 enrolled

Gastrointestinal

Colonic Neoplasms

NCT00008281 2014-01-06

Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Phase 3 Unknown

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00002692 2013-12-19

Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver

Phase 3 Unknown

312 enrolled

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT00002893 2013-12-19

Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer

Phase 3 Unknown

900 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00021281 2013-12-19

Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer

Phase 3 Unknown

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00617071 2013-12-18

Personalized Screening Plans to Increase Colorectal Cancer Screening in Healthy Participants

Phase 3 Unknown

900 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00893295 2013-12-18

Increasing Colorectal Cancer Screening in African Americans

Phase 3 Unknown

896 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00003063 2013-09-20

Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer

Phase 3 Unknown

1,050 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00046995 2013-09-20

Combination Chemotherapy in Treating Patients With Colon Cancer

Phase 3 Unknown

800 enrolled

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00002793 2013-09-17

Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer

Phase 3 Unknown

336 enrolled

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT00182715 2013-09-17

Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Phase 3 Unknown

2,421 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00797485 2013-08-26

Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Phase 3 Unknown

672 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00002455 2013-08-07

Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma

Phase 3 Unknown

BreastDermatologicGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Melanoma, Colorectal Neoplasms

NCT00559858 2013-08-02

Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast Cancer

Phase 3 Unknown

270 enrolled

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms, Breast Neoplasms, Male, Hand-Foot Syndrome

NCT00482222 2013-01-23

Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer

Phase 3 Unknown

340 enrolled

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT01589146 2012-05-01

PRO-LAPS I

Phase 3 Unknown

400 enrolled

Gastrointestinal

Colonic Neoplasms

NCT00006479 2011-04-18

Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer

Phase 3 Unknown

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Rectal Neoplasms, Colorectal Neoplasms

NCT00091312 2009-02-09

Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer

Phase 3 Unknown

1,976 enrolled

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT00003260 2009-01-13

Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer

Phase 3 Unknown

109 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00006468 2009-01-13

Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Phase 3 Unknown

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00337389 2007-11-19

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

Phase 3 Unknown

1,200 enrolled

Gastrointestinal

Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00387842 2006-10-13

COlon Cancer Laparoscopic or Open Resection

Phase 3 Unknown

1,200 enrolled

Gastrointestinal

Colonic Neoplasms

NCT00295035 2006-02-22

Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer

Phase 3 Unknown

100 enrolled

Gastrointestinal

Colonic Neoplasms

Clinical Trials

SPACE

ASCOLT

TWICE-IRI

IDEA

PROMENADE

The Efficacy and Safety of Modified XELOX(mXELOX) Plus Cetuximab vs FOLFOX Plus Cetuximab in RAS and BRAF WT mCRC Pts

AVOID

HATCHED

The Value of Palliative Primary Tumor Resection in Metastatic Colon Cancer

Adjuvant Chemotherapy in High Risk Stage II Colon Cancer

EPAC1

MAPOCD

Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy

Peripheral Parenteral Nutrition vs Conventional Fluid in Colorectal Resection in ERAS

CLIMAT

PEPCORLI

Laparoscopic Surgery for T4 Tumor of the Colon Cancer

OLCMECC

Cytokine-induced Killer Cell Immunotherapy for Surgical Resected Stage III Colorectal Cancer Patients After Chemotherapy

Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver

Palliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer

Combination Chemotherapy With or Without SU5416 in Treating Patients With Metastatic Colorectal Cancer

Personalized Screening Plans to Increase Colorectal Cancer Screening in Healthy Participants

Increasing Colorectal Cancer Screening in African Americans

Biological Therapy With Combination Chemotherapy in Patients With Colorectal Cancer

Combination Chemotherapy in Treating Patients With Colon Cancer

Chemotherapy Via an Implantable Pump Compared With a Subcutaneous Port for Unresectable Liver Metastases in Patients With Resected Colorectal Cancer

Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer

Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma

Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast Cancer

Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer

PRO-LAPS I

Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer

Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer

Combination Chemotherapy in Treating Patients With Recurrent Metastatic Colorectal Cancer

Comparing Two Combination Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

COlon Cancer Laparoscopic or Open Resection

Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Metastatic Colon Cancer